Skip to main content
. 2019 Jan 27;18(2):e12898. doi: 10.1111/acel.12898

Table 1.

Effects of three different doses of ACA on lifespan

Group N Median lifespan Lifespan at 90th percentile
Days % change p‐value Days % change Wang–Allison p‐value
Females
Cont_13 287 889 1,097
ACA_lo 139 887 0% 0.03 1,123 2% 0.37
ACA_mid 142 933 5% 0.003 1,125 3% 0.007
ACA_hi 152 922 4% 0.006 1,125 3% 0.10
UA 147 885 0% 0.49 1,084 –1% 0.46
Cont_12 279 877 1,100
HBX 136 856 –2% 0.4 1,091 –1% NS
I767d 136 868 –1% 0.8 1,102 0% NS
Males
Cont_13 273 830 1,089
ACA_lo 147 918 11% <0.0001 1,211 11% 0.0004
ACA_mid 161 975 17% <0.0001 1,210 11% 0.0004
ACA_hi 163 964 16% <0.0001 1,181 8% 0.0001
UA 151 883 6% 0.38 1,092 0% 0.91
Cont_12 284 816 1,055
HBX 155 822 1% 0.4 1,069 1% NS
I767d 147 791 –3% 0.11 1,012 –4% NS

Lifespans of ITP mice from cohorts 2013 and 2012. Cont_13 = controls for cohort started in 2013; Cont_12 = controls for cohort started in 2012. N = number of mice tested; data were pooled, with about 1/3 from each testing site. Probabilities that lifespans are the same as the controls in column 4 (p‐value) used two‐tailed log‐rank test on pooled data stratified by sites; “removed” mice were included in these calculations. Probabilities that the proportion of live mice is the same in treated as in the control group at the 90th percentile age are evaluated by the procedure of Wang et al., (2004). Amounts of ACA in diet: hi = 2,500 ppm; mid = 1,000 ppm; lo = 400 ppm. UA, HBX, and 1767d had no significant effect on lifespan in the doses used.

NS: not significant.